Richard Steinhart - Chief Financial Officer at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
BTAI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Richard Steinhart - trading volume in the past year for BioXcel Therapeutics, Inc.

Holdings reported by Richard Steinhart for BioXcel Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 6.44K $9.21K $1.43 Jul 22, 2025 Direct
Restricted Stock Units 317 $136 $0.35 Sep 15, 2025 Direct Common Stock
Stock Option (right to buy) 270K Jan 7, 2025 Direct Common Stock

Transactions reported by Richard Steinhart for BioXcel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.